Trial
NCT03996460
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Georgetown University
Collaborators
Sun Pharma Advanced Research Company Limited
Condition
Dementia With Lewy Bodies
Intervention
Placebo
Why stopped
Interim analysis was performed for 442 patients who completed Part I of the PROSEEK study-(CLR\_18\_06); it did not show evidence of treatment benefit in patients receiving Vodobatinib.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-08